The Board of Directors of Pediapharm Inc. has decided, following the amalgamation with Chelsea Acquisition Corporation completed on December 10, 2013, to change the corporation's financial year-end from December 31 to March 31.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.82 CAD | +4.60% | +7.69% | -26.32% |
06-26 | Transcript : Medexus Pharmaceuticals Inc., Q4 2024 Earnings Call, Jun 26, 2024 | |
06-06 | Medexus Pharmaceuticals Inc. Announces FDA Accepts for Review Treosulfan NDA | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.32% | 32.52M | |
+55.32% | 815B | |
+44.05% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+13.31% | 218B | |
+8.48% | 168B | |
-2.81% | 159B |
- Stock Market
- Equities
- MDP Stock
- News Medexus Pharmaceuticals Inc.
- Pediapharm Inc. Announces Change of Financial Year-End from December 31 to March 31